Related Experiment Videos
Cell death in the heart
R A Lockshin1, C O Facey, Z Zakeri
1Department of Biological Sciences, St. John's University, Jamaica, New York 11439, USA. lockshin@stjohns.edu
Cardiology Clinics
|January 15, 2002
Summary
Apoptosis in cardiac disease is complex, often reflecting inflammation rather than myocyte death. Targeting apoptosis may benefit acute cardiac events, but its role in chronic conditions requires careful cell-type and timing analysis.
Area of Science:
- Cardiovascular Biology
- Cell Death Mechanisms
- Pathology
Background:
- The role of apoptosis (programmed cell death) in cardiac disease is debated.
- Apoptosis detected in the heart may stem from inflammatory cells rather than cardiomyocytes (heart muscle cells).
- Myocyte apoptosis might be a consequence, not a cause, of end-stage heart failure.
Purpose of the Study:
- To clarify the significance of apoptosis in various cardiovascular diseases.
- To investigate the potential therapeutic value of anti-apoptotic agents in acute cardiac conditions.
- To emphasize precise documentation of cell death timing and cell types in cardiac research.
Main Methods:
- Ultra-structural analysis to identify apoptosis in cardiomyocytes, fibroblasts, endothelial cells, and smooth muscle cells.
- Distinguishing myocyte apoptosis from inflammatory cell apoptosis.
- Evaluating the timing and cellular origins of cell death in cardiac pathology.
Main Results:
- Apoptosis is prevalent across multiple cell types in the diseased heart.
- Distinguishing apoptosis from necrosis and other cell death forms is challenging in intact organs.
- Inflammatory cell apoptosis can worsen cardiac conditions, while myocyte apoptosis often indicates end-stage failure.
Conclusions:
- Further research into apoptosis's role in cardiac disease is warranted.
- Anti-apoptotic strategies may offer benefits in acute cardiac events like infarction.
- Careful consideration of cell type, timing, and methodology is crucial for interpreting cardiac cell death.